CD44 and neoplasm: Molecular studies demonstrated treatment of SKOV cells with MDA-MB-231-derived exosomes increased miR-454 expression in CD44 + /CD133 + SKOV cells through the activation of the Wnt pathway via proline rich transmembrane protein 2 binding and increased stemness in vitro and tumor growth in vivo [106].